Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NexEos Diagnostics
AddedFeb 15, 2024
UpdatedJun 18, 2026
NexEos Diagnostics

NexEos Diagnostics

Series A

NexEos Diagnostics, Inc., a Pennsylvania-based medical firm, innovates diagnostic tools for chronic, eosinophil-related diseases.

HQ
Pottstown, PA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

NexEos Diagnostics, Inc., founded in Pottstown, Pennsylvania, is a privately held medical diagnostics company focused on improving the diagnosis, management, and treatment of chronic, eosinophil-related inflammatory diseases. The company's core mission is to develop and commercialize novel technologies that address the unmet needs of patients suffering from these conditions. Their lead product is a rapid, non-invasive imaging agent designed for the diagnosis and monitoring of Eosinophilic Esophagitis (EoE).

Notable affiliated individuals and investors have not been disclosed, but the company has achieved significant milestones in advancing its lead program. NexEos Diagnostics' innovative approach has the potential to significantly impact patient care by providing better diagnostic tools and improving disease management. Their work aims to bring new hope to patients with eosinophil-related diseases, making a meaningful difference in their quality of life.

NexEos Diagnostics - Similar Companies

Eclipse Diagnostics logo

Eclipse Diagnostics

NX Pharmagen logo

NX Pharmagen

nxpharmagen.com

Celestia Diagnostics logo

Celestia Diagnostics

Test Diagnostics logo

Test Diagnostics

Lucid Diagnostics logo

Lucid Diagnostics

luciddx.com

Neodiagnostix logo

Neodiagnostix

neodiagnostix.com

Nowdiagnostics logo

Nowdiagnostics

nowdx.com

Evanostics logo

Evanostics

Nexosome Oncology logo

Nexosome Oncology

Epinex Diagnostics logo

Epinex Diagnostics

epinex.com

Empowered Diagnostics logo

Empowered Diagnostics

NAT Diagnostics logo

NAT Diagnostics

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

IES Diagnostics logo

IES Diagnostics

NexEos Diagnostics - Quick Facts

Who are NexEos Diagnostics' competitors?

Companies similar to NexEos Diagnostics include Eclipse Diagnostics, NX Pharmagen, Celestia Diagnostics and Test Diagnostics.

When was NexEos Diagnostics founded?

NexEos Diagnostics was founded in 2019.

Where is NexEos Diagnostics' headquarters located?

NexEos Diagnostics' headquarters is located in Pottstown, PA, US.

When was NexEos Diagnostics' last funding round?

NexEos Diagnostics' most recent funding round was for $5.1M (USD) in February 2023.

How much has NexEos Diagnostics raised to-date?

As of Feb 15, 2023, NexEos Diagnostics has raised a total of $17.8M (USD).

How many employees does NexEos Diagnostics have?

NexEos Diagnostics has 30 employees as of Feb 5, 2024.

NexEos Diagnostics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Diagnostics
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies